News ArchivesRead News
Symptoms of Parkinson's disease linked to fungus
Monday November 11, 2013
Medical Xpress - Scientists at Rutgers and Emory universities have discovered that a compound often emitted by mold may be linked to symptoms of Parkinson's disease.
Arati Inamdar and Joan Bennett, researchers in the School of Environmental and Biological Sciences at Rutgers, used fruit flies to establish the connection between the compound – popularly known as mushroom alcohol – and the malfunction of two genes involved in the packaging and transport of dopamine, the chemical released by nerve cells to send messages to other nerve cells in the brain.
The findings were published online today in the Proceedings of the National Academy of Sciences.
"Parkinson's has been linked to exposure to environmental toxins, but the toxins were man-made chemicals," Inamdar said. "In this paper, we show that biologic compounds have the potential to damage dopamine and cause Parkinson's symptoms."
For co-author Bennett, the research was more than academic. Bennett was working at Tulane University in New Orleans when Hurricane Katrina struck the Gulf Coast in 2005. Her flooded house became infested with molds, which she collected in samples, wearing a mask, gloves and protective gear.
"I felt horrible – headaches, dizziness, nausea," said Bennett, now a professor of plant pathology and biology at Rutgers. "I knew something about 'sick building syndrome' but until then I didn't believe in it. I didn't think it would be possible to breathe in enough mold spores to get sick." That is when she formed her hypothesis that volatiles might be involved.
Inamdar, who uses fruit flies in her research, and Bennett began their study shortly after Bennett arrived at Rutgers. Bennett wanted to understand the connection between molds and symptoms like those she had experienced following Katrina.
The scientists discovered that the volatile organic compound 1-octen-3-ol, otherwise known as mushroom alcohol, can cause movement disorders in flies, similar to those observed in the presence of pesticides, such as paraquat and rotenone. Further, they discovered that it attacked two genes that deal with dopamine, degenerating the neurons and causing the Parkinson's-like symptoms.
Studies indicate that Parkinson's disease – a progressive disease of the nervous system marked by tremor, muscular rigidity and slow, imprecise movement—is increasing in rural areas, where it's usually attributed to pesticide exposure. But rural environments also have a lot of mold and mushroom exposure.
"Our work suggests that 1-octen-3-ol might also be connected to the disease, particularly for people with a genetic susceptibility to it," Inamdar said. "We've given the epidemiologists some new avenues to explore."
Bennett, also associate vice president for the promotion of women in science, engineering and mathematics at Rutgers, and Inamdar were joined by co-author Muhammad Hossein and Jason Richardson from Robert Wood Johnson Medical School, and Alison Bernstein and Gary Miller of Emory University.
(11 Nov. 2013) Medical Xpress. Symptoms of Parkinson's disease linked to fungus. www.medicalxpress.com.
Recent NewsOct 18 - Brain disconnections may contribute to Parkinson's hallucinations
Oct 18 - Fighting Parkinson's disease through dance
Oct 17 - Scientists Identify Structure of PINK1, Key Parkinson’s-protective Protein
Oct 17 - Diabetes drug cuts Parkinson's risk by 28 percent, study finds
Oct 10 - Advances in Brain Pacemaker Reduces Tremors, Helps Parkinson's Sufferers Live a More Normal Life
Oct 10 - Medical History Could Help Predict Parkinson's Disease Risk Long Before Diagnosis
Oct 3 - Changes in Olfactory Bulb Explain Loss of Smell in Early Stages of Parkinson’s Disease, Study Finds
Oct 3 - Sleep Disturbances May Worsen Motor Symptoms in Parkinson’s Disease, Study Suggests
Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show